Diabetes and metabolic syndrome
Frontiers in Clinical Drug Research – Diabetes and Obesity is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases – diabetes and obesity. The scope of the series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research.
The fifth volume of this series features 5 reviews which are informative guides to therapy and drug administration in diabetes and metabolic syndrome, for both the medical specialist and the pharmacologist.
- Metabolic syndrome in schizophrenia
- Insulin therapy and foetoplacental endothelial dysfunction in gestational diabetes mellitus
- Insights on diabetes, oxidative stress and antioxidant therapeutic strategies
- Administration of Nano drugs in the treatment of diabetes mellitus
- SGLT-2 inhibitors
About the Editor:
Prof. Atta-ur-Rahman, Ph.D. in organic chemistry from Cambridge University (1968), has 1080 international publications in several fields of organic chemistry including 751 research publications, 37 international patents, 69 chapters in books and 221 books published largely by major U.S. and European presses. He is the Editor-in-Chief of eight European Chemistry journals. He is Editor of the world’s leading encyclopedic series of volumes on natural products ‘Studies in Natural Product Chemistry’ 54 volumes of which have been published under his Editorship by Elsevier during the last two decades.
Prof. Rahman won the UNESCO Science Prize (1999) and was elected as Fellow of the prestigious Royal Society (London) in July 2006. He has been conferred honorary doctorate degrees by many universities including (Sc.D.) by the Cambridge University (UK) (1987). He was elected Honorary Life Fellow of Kings College, Cambridge University, UK, conferred the TWAS (Italy) Prize and the Austrian government has honored him with its high civil award (“Grosse Goldene Ehrenzeischen am Bande”) (2007). He is Foreign Fellow of Chinese and Korean Academy of Sciences, Foreign Fellow of the Chinese Chemical Society and former President of Pakistan Academy of Sciences.
Diabetes, obesity, metabolic diseases, clinical trials, Insulin therapy, synthetic drugs, molecular biology, biochemistry, medicinal chemistry, pharmacology
For further information, please visit: https:/
Faizan ul Haq